We regularly ask our product experts and industry leaders to talk about topics that matter to our customers. Helping you to overcome real-world research problems, answering your technical questions, or highlighting our latest product innovations, our webinar series has something for everyone.
If you missed a webinar, then we’re pleased to offer you FREE access to our library of informative, engaging and interactive presentations. Simply click on the relevant link to watch the webinar.
If you’d like to see what we’ve got coming up, please visit our events page which is updated regularly with new webinars, global events, seminars and trade shows.
The first of the series ' Lateral flow assay development - key fundamentals when considering your outsourcing partner' is Webinar 1 – Characteristics of gold nanoparticles for immunoconjugation.
View our webinar and listen to our in-house experts Nikki Robinson, Technical Support Leader and Chris Jones, Technical Support Scientist explore Gold Conjugates.
Understanding the regulation of mobile apps with a medical purpose is essential, as the future of healthcare shifts towards decentralised point of care testing (POCT).
View our webinar recording and listen to Dr Alasdair Christie, Head of Regulated Product at Novarum™ Dx, as he discusses the regulatory frameworks and process controls required to develop a mobile medical app.
Join us for our webinar; 'Selecting Antibodies for Infectious Disease Immunoassays', with our in-house antibody development expert Dr Stephen Pelsue.
The webinar focuses on immunoassay detection of infectious diseases and some of the key antibody characteristics for the development of specific and sensitive detection of bacterial and viral pathogens.
Custom Antibody Development Approaches for Generating Anti-Idiotype Monoclonal Antibodies for PK Assays
Join Dr. Stephen Pelsue, Science Director at BBI Solutions, in our webinar focused on the development of anti-idiotype (anti-id) antibodies. Anti-id monoclonal antibodies are critical for bioanalytical pharmacokinetic (PK) assays that are required to ensure the safety and efficacy of therapeutic antibody drugs.
The convergence of point of care testing (POCT) and the mobile phone has the potential to revolutionise diagnostics. Yet, misconceptions exist about the capability of a smartphone to accurately read and share the results of diagnostic tests.Download our webinar recording as we myth bust the common misconceptions surrounding smartphone readers and demonstrate how the technology is already transforming point of care testing.
Join Dr. Neil Polwart, Founder of Novarum and BBI Group Head of Mobile in our webinar, where he will discuss how the healthcare sector is on the verge of a mhealth revolution and demonstrate how a lateral flow test can support home testing and self-patient care using nothing more than a smartphone.
In this webinar Dr. Catharine Sturgeon from UK NEQAS sets out the case for an international effort to standardise manufacturer’s assays for mucin tumour markers, such as CA125, CA15-3 and CA19-9. If the benefits of standardisation clearly improve between-laboratory comparability of immunoassay results, then this could be a key consideration for endorsement by governing bodies in the future. Stay ahead of the game and learn how you can future proof your tumour marker assay.